Amid med­dling con­cerns, FDA con­venes ad­comm for Pfiz­er/BioN­Tech boost­er

The FDA’s pan­el of out­side vac­cine ad­vi­sors is set to meet in two weeks and dis­cuss Pfiz­er and BioN­Tech’s sBLA ap­pli­ca­tion for a third, boost­er shot of their Covid-19 vac­cine — just three days be­fore the Biden ad­min­is­tra­tion said it would roll out boost­ers.

Reg­u­la­tors re­ceived the sBLA just a week ago, and they will be look­ing to those ex­perts to in­form their de­ci­sion mak­ing, said CBER chief Pe­ter Marks.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER